10x Genomics Inc $ 164.39 0.69 (0.42%)
Volume:
65,998
Avg Vol (1m):
811,645
Market Cap $:
17.50 Bil
Enterprise Value $:
17.22 Bil
P/E (TTM):
0.00
P/B:
41.97
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 5.74 | ||
| Equity-to-Asset | 0.67 | ||
| Debt-to-Equity | 0.15 | ||
| Debt-to-EBITDA | -0.97 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 54.71 | ||
| Beneish M-Score | -3.11 | ||
Profitability Rank | 1/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -30.43 | ||
| Net Margin % | -31.06 | ||
| ROE % | -23.55 | ||
| ROA % | -15.44 | ||
| ROC (Joel Greenblatt) % | -107.89 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 41.97 | ||
| PS Ratio | 40.38 | ||
| Price-to-Operating-Cash-Flow | 674.04 | ||
| EV-to-EBIT | -231.04 | ||
| EV-to-EBITDA | -282.67 | ||
| EV-to-Revenue | 68.53 | ||
| Current Ratio | 3.7 | ||
| Quick Ratio | 3.52 | ||
| Days Inventory | 104.63 | ||
| Days Sales Outstanding | 33.01 | ||
| Days Payable | 63.25 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History |
|---|
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 42 | ||
| Earnings Yield (Greenblatt) % | -0.43 |